Bal Pharma Limited

NSE BALPHARMA.NS

Bal Pharma Limited Price to Sales Ratio (P/S) on February 07, 2025: 0.50

Bal Pharma Limited Price to Sales Ratio (P/S) is 0.50 on February 07, 2025, a -21.31% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Bal Pharma Limited 52-week high Price to Sales Ratio (P/S) is 0.70 on August 28, 2024, which is 41.35% above the current Price to Sales Ratio (P/S).
  • Bal Pharma Limited 52-week low Price to Sales Ratio (P/S) is 0.45 on April 01, 2024, which is -9.68% below the current Price to Sales Ratio (P/S).
  • Bal Pharma Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 0.55.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
SV Wall Street
NSE: BALPHARMA.NS

Bal Pharma Limited

CEO Mr. Shailesh Dheerajmal Siroya
IPO Date May 8, 2006
Location India
Headquarters Lakshmi Narayan Complex
Employees 868
Sector Consumers Staples
Industries
Description

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostrate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. The company also offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, etc.; and various formulations. In addition, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to Europe, Latin America, Africa, the Far East, the Middle East, and internationally. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Similar companies

BIL.NS

Bhartiya International Ltd.

USD 8.02

1.40%

BSL.NS

BSL Limited

USD 2.33

-1.54%

ALPA.NS

Alpa Laboratories Limited

USD 1.31

-1.18%

AURIONPRO.NS

Aurionpro Solutions Limited

USD 17.81

0.45%

StockViz Staff

February 8, 2025

Any question? Send us an email